Solvay Pharma India (SPIL) was incorporated in 2002 as a consequence of the demerger of pharma business of Duphar-Interfran. Solvay Pharma India has presence in the field of women’s health, gastroenterology, mental health and influenza vaccines. Deeply rooted in these specialty segments SPIL is a leader with its competent products and innovative solutions. The company strives to provide the health care industry with newer & quality products that are effective and safe in areas where clinical need for treatment is most urgent.
Psychiatry / ENT / Neurology
Solvay is an international chemical and pharmaceutical group with headquarters in Brussels. In India, Solvay is present in the pharmaceutical sector through its group company Solvay Pharma India. The company is head quartered at Mumbai and employs more than 450 people throughout India. It operates through two sales divisions and reaches out to its customers across the country through more than 1100 distributors. Currently the company structures itself into 2 Divisions, aided with its dedicated sales force and focusing on specialties and super specialties.
With research as the backbone, most of the products are brand leaders in their respective therapeutic segments. High level of scientific interaction, intense product knowledge enables the team to meet the ever-changing needs of medicine. New Product Introduction is advocated actively and the company plans to launch new products each year in either divisions.